## First-Line Treatment of Bipolar II Depressive Episode **Key Point:** Lamotrigine is the first-line mood stabilizer for bipolar II depression and is the only anticonvulsant with evidence-based efficacy specifically for the depressive phase of bipolar disorder. ### Why Lamotrigine Is First-Line for Bipolar II Depression 1. **Mechanism**: Inhibits glutamate release; does NOT work for acute mania (unlike lithium or valproate) 2. **Efficacy**: 50–60% response rate in bipolar depression; superior to placebo in RCTs 3. **Safety in bipolar II**: No risk of mood destabilization or switch to hypomania (unlike SSRIs) 4. **Dosing**: Start 25 mg daily, titrate slowly to 100–200 mg daily (slow titration reduces rash risk) 5. **Maintenance**: Effective for preventing depressive relapse in bipolar II ### Bipolar II vs. Bipolar I: Treatment Differences | Feature | Bipolar I | Bipolar II | |---------|-----------|----------| | **Mania severity** | Full mania (severe) | Hypomania only (mild–moderate) | | **Depressive burden** | ~40% of episodes | ~70% of episodes | | **First-line for depression** | Lithium, quetiapine | **Lamotrigine** | | **SSRI risk** | High switch risk | Lower but still present | | **Mood stabilizer choice** | Lithium, valproate | Lamotrigine, quetiapine | **Clinical Pearl:** Bipolar II patients spend more time depressed than hypomanic, so antidepressant selection is critical. Lamotrigine's lack of manic switch risk makes it ideal for this population. **High-Yield:** Lamotrigine is **ineffective for acute mania** but **excellent for bipolar depression and maintenance**. This is a frequent NEET PG trap — students confuse it with valproate or lithium. **Mnemonic:** **LAM** = **L**amotrigine for **A**ffective (depressive) **M**ood in bipolar II. ### Why SSRIs Alone Are Contraindicated - Risk of mood switch to hypomania/mania (10–30% in bipolar II) - Must always be paired with a mood stabilizer if used - Lamotrigine avoids this risk entirely **Warning:** Sertraline monotherapy (option A) violates the cardinal rule: never use antidepressants alone in bipolar disorder without a mood stabilizer. The patient has already had hypomanic episodes, so SSRI monotherapy risks destabilization.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.